Literature DB >> 18755689

The Gi-coupled P2Y12 receptor regulates diacylglycerol-mediated signaling in human platelets.

Gianni F Guidetti1, Paolo Lova, Bruno Bernardi, Francesca Campus, Gianluca Baldanzi, Andrea Graziani, Cesare Balduini, Mauro Torti.   

Abstract

Stimulation of G(q)-coupled receptors activates phospholipase C and is supposed to promote both intracellular Ca(2+) mobilization and protein kinase C (PKC) activation. We found that ADP-induced phosphorylation of pleckstrin, the main platelet substrate for PKC, was completely inhibited not only by an antagonist of the G(q)-coupled P2Y1 receptor but also upon blockade of the G(i)-coupled P2Y12 receptor. The role of G(i) on PKC regulation required stimulation of phosphatidylinositol 3-kinase rather than inhibition of adenylyl cyclase. P2Y12 antagonists also inhibited pleckstrin phosphorylation, Rap1b activation, and platelet aggregation induced upon G(q) stimulation by the thromboxane A(2) analogue U46619. Importantly, activation of phospholipase C and intracellular Ca(2+) mobilization occurred normally. Phorbol 12-myristate 13-acetate overcame the inhibitory effect of P2Y12 receptor blockade on PKC activation but not on Rap1b activation and platelet aggregation. By contrast, inhibition of diacylglycerol kinase restored both PKC and Rap1b activity and caused platelet aggregation. Stimulation of P2Y12 receptor or direct inhibition of diacylglycerol kinase potentiated the effect of membrane-permeable sn-1,2-dioctanoylglycerol on platelet aggregation and pleckstrin phosphorylation, in association with inhibition of its phosphorylation to phosphatidic acid. These results reveal a novel and unexpected role of the G(i)-coupled P2Y12 receptor in the regulation of diacylglycerol-mediated events in activated platelets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755689      PMCID: PMC2661997          DOI: 10.1074/jbc.M801588200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Central role of the P2Y12 receptor in platelet activation.

Authors:  Robert T Dorsam; Satya P Kunapuli
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 2.  Diacylglycerol kinases.

Authors:  Bai Luo; Debra S Regier; Stephen M Prescott; Matthew K Topham
Journal:  Cell Signal       Date:  2004-09       Impact factor: 4.315

3.  A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.

Authors:  D L Nunn; S P Watson
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

4.  Stimulation of human platelets with concanavalin A involves phospholipase C activation.

Authors:  M Torti; C Balduini; G Ramaschi; F Sinigaglia
Journal:  Cell Biochem Funct       Date:  1992-03       Impact factor: 3.685

5.  Molecular cloning and expression of the major protein kinase C substrate of platelets.

Authors:  M Tyers; R A Rachubinski; M I Stewart; A M Varrichio; R G Shorr; R J Haslam; C B Harley
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

6.  Inositol phospholipid metabolism in human platelets stimulated by ADP.

Authors:  J D Vickers; R L Kinlough-Rathbone; M A Packham; J F Mustard
Journal:  Eur J Biochem       Date:  1990-10-24

7.  Purification and characterization of cytosolic diacylglycerol kinases of human platelets.

Authors:  Y Yada; T Ozeki; H Kanoh; Y Nozawa
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

8.  Attenuation of sn-1,2-diacylglycerol second messengers. Metabolism of exogenous diacylglycerols by human platelets.

Authors:  W R Bishop; R M Bell
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

9.  Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.

Authors:  M A Packham; A A Livne; D H Ruben; M L Rand
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

10.  Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets.

Authors:  Adam R Hardy; Matthew L Jones; Stuart J Mundell; Alastair W Poole
Journal:  Blood       Date:  2004-06-08       Impact factor: 22.113

View more
  17 in total

Review 1.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

2.  Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets.

Authors:  Dongjun Li; Lauren D'Angelo; Massiel Chavez; Donna S Woulfe
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

3.  Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation.

Authors:  Alyssa J Moroi; Nicole M Zwifelhofer; Matthew J Riese; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2019-04-09

Review 4.  Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy.

Authors:  Timothy D Warner; Sven Nylander; Carl Whatling
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

Review 5.  The genetics of common variation affecting platelet development, function and pharmaceutical targeting.

Authors:  A D Johnson
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling.

Authors:  Weiqun Yu; Xiaofeng Sun; Simon C Robson; Warren G Hill
Journal:  FASEB J       Date:  2014-09-10       Impact factor: 5.191

7.  Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.

Authors:  Andrew D Johnson; Lisa R Yanek; Ming-Huei Chen; Nauder Faraday; Martin G Larson; Geoffrey Tofler; Shiow J Lin; Aldi T Kraja; Michael A Province; Qiong Yang; Diane M Becker; Christopher J O'Donnell; Lewis C Becker
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

8.  Inhibitory effects of total saponin from Korean Red Ginseng on [Ca(2+)]i mobilization through phosphorylation of cyclic adenosine monophosphate-dependent protein kinase catalytic subunit and inositol 1,4,5-trisphosphate receptor type I in human platelets.

Authors:  Jung-Hae Shin; Hyuk-Woo Kwon; Hyun-Jeong Cho; Man Hee Rhee; Hwa-Jin Park
Journal:  J Ginseng Res       Date:  2015-03-28       Impact factor: 6.060

9.  Inhibitory Effects of Cytosolic Ca(2+) Concentration by Ginsenoside Ro Are Dependent on Phosphorylation of IP3RI and Dephosphorylation of ERK in Human Platelets.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Dong-Ha Lee; Hwa-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-19       Impact factor: 2.629

10.  Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases.

Authors:  Yu Lu; Quan Li; Yu-Ying Liu; Kai Sun; Jing-Yu Fan; Chuan-She Wang; Jing-Yan Han
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.